Cargando…
Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028848/ https://www.ncbi.nlm.nih.gov/pubmed/27699179 http://dx.doi.org/10.1155/2016/2129838 |
_version_ | 1782454411152326656 |
---|---|
author | Graumlich, James F. Wang, Huaping Madison, Anna Wolf, Michael S. Kaiser, Darren Dahal, Kumud Morrow, Daniel G. |
author_facet | Graumlich, James F. Wang, Huaping Madison, Anna Wolf, Michael S. Kaiser, Darren Dahal, Kumud Morrow, Daniel G. |
author_sort | Graumlich, James F. |
collection | PubMed |
description | Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients' medication knowledge, adherence, and glycemic control compared to usual care. Design. A multicenter, randomized controlled trial in outpatient primary care clinics. 674 patients received either the Medtable tool or usual care and were followed up for up to 12 months. Results. Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications. Patients' knowledge of drug indication improved with Medtable regardless of their literacy status. However, Medtable did not improve patients' demonstrated medication use, regimen adherence, or glycemic control (HbA1c). Conclusion. The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes. This trial is registered with ClinicalTrials.gov NCT01296633. |
format | Online Article Text |
id | pubmed-5028848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-50288482016-10-03 Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial Graumlich, James F. Wang, Huaping Madison, Anna Wolf, Michael S. Kaiser, Darren Dahal, Kumud Morrow, Daniel G. J Diabetes Res Clinical Study Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients' medication knowledge, adherence, and glycemic control compared to usual care. Design. A multicenter, randomized controlled trial in outpatient primary care clinics. 674 patients received either the Medtable tool or usual care and were followed up for up to 12 months. Results. Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications. Patients' knowledge of drug indication improved with Medtable regardless of their literacy status. However, Medtable did not improve patients' demonstrated medication use, regimen adherence, or glycemic control (HbA1c). Conclusion. The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes. This trial is registered with ClinicalTrials.gov NCT01296633. Hindawi Publishing Corporation 2016 2016-09-06 /pmc/articles/PMC5028848/ /pubmed/27699179 http://dx.doi.org/10.1155/2016/2129838 Text en Copyright © 2016 James F. Graumlich et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Graumlich, James F. Wang, Huaping Madison, Anna Wolf, Michael S. Kaiser, Darren Dahal, Kumud Morrow, Daniel G. Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial |
title | Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial |
title_full | Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial |
title_fullStr | Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial |
title_full_unstemmed | Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial |
title_short | Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial |
title_sort | effects of a patient-provider, collaborative, medication-planning tool: a randomized, controlled trial |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028848/ https://www.ncbi.nlm.nih.gov/pubmed/27699179 http://dx.doi.org/10.1155/2016/2129838 |
work_keys_str_mv | AT graumlichjamesf effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial AT wanghuaping effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial AT madisonanna effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial AT wolfmichaels effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial AT kaiserdarren effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial AT dahalkumud effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial AT morrowdanielg effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial |